ARMEN GARO H

SEC source: 0000950170-25-018064 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,568

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending February 7, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $3.50 is the closing price of our Common Stock on February 7, 2025, the payroll date for the pay period ending February 7, 2025.

SEC source: 0000950170-25-009792 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,317

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending January 24, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $3.57 is the closing price of our Common Stock on January 24, 2025, the payroll date for the pay period ending January 24, 2025.

SEC source: 0000950170-25-004815 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,148

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending January 10, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $3.12 is the closing price of our Common Stock on January 10, 2025, the payroll date for the pay period ending January 10, 2025.

SEC source: 0000950170-24-141123 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,371

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending December 27, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $2.75 is the closing price of our Common Stock on December 27, 2024, the payroll date for the pay period ending December 27, 2024.

SEC source: 0000950170-24-136622 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,440

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending December 13, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $3.05 is the closing price of our Common Stock on December 13, 2024, the payroll date for the pay period ending December 13, 2024.

SEC source: 0000950170-24-132515 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,093

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending November 29, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $3.42 is the closing price of our Common Stock on November 29, 2024, the payroll date for the pay period ending November 29, 2024.

SEC source: 0000950170-24-127933 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,324

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending November 15, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $2.72 is the closing price of our Common Stock on November 15, 2024, the payroll date for the pay period ending November 15, 2024.

SEC source: 0000950170-24-127933 · ownership.xml · derivative · entry 4

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2034-11-14

F5 · derivative.exercise_date: Represents a one-time retention award comprised of options to purchase common stock, which were granted to certain key employees, including our executive officers. These options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan and will vest on November 15, 2025.

SEC source: 0000950170-24-120363 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,327

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending November 1, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $4.05 is the closing price of our Common Stock on November 1, 2024, the payroll date for the pay period ending November 1, 2024.

SEC source: 0000950170-24-115885 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,300

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending October 18, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $4.62 is the closing price of our Common Stock on October 18, 2024, the payroll date for the pay period ending October 18, 2024.

SEC source: 0000950170-24-113183 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,770

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending October 4, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $4.87 is the closing price of our Common Stock on October 4, 2024, the payroll date for the pay period ending October 4, 2024.

SEC source: 0000950170-24-108934 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,421

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending September 20, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $5.84 is the closing price of our Common Stock on September 20, 2024, the payroll date for the pay period ending September 20, 2024.

SEC source: 0000950170-24-104710 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,628

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending September 6, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $4.95 is the closing price of our Common Stock on September 6, 2024, the payroll date for the pay period ending September 6, 2024.

SEC source: 0000950170-24-100797 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,333

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending August 23, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $5.47 is the closing price of our Common Stock on August 23, 2024, the payroll date for the pay period ending August 23, 2024.

SEC source: 0000950170-24-095518 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,351

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending August 9, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $5.09 is the closing price of our Common Stock on August 9, 2024, the payroll date for the pay period ending August 9, 2024.

SEC source: 0000950170-24-087252 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,147

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending July 26, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $6.56 is the closing price of our Common Stock on July 26, 2024, the payroll date for the pay period ending July 26, 2024.

SEC source: 0000950170-24-083417 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,661

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending July 12, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $15.60 is the closing price of our Common Stock on July 12, 2024, the payroll date for the pay period ending July 12, 2024.

SEC source: 0000950170-24-079638 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,615

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending June 14, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $16.75 is the closing price of our Common Stock on June 28, 2024, the payroll date for the pay period ending June 28, 2024.

SEC source: 0000950170-24-074741 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,642

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending June 14, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $15.46 is the closing price of our Common Stock on June 14, 2024, the payroll date for the pay period ending June 14, 2024.

SEC source: 0000950170-24-074741 · ownership.xml · derivative · entry 5

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,000

Underlying: Common Stock · 108,000 shares

Expires 2034-01-11

F6 · derivative.exercise_date: Options were granted on January 17, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on January 16, 2025 and the balance vesting in equal quarterly installments thereafter. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 2,160,000 Stock Options with an exercise price of $0.59.

SEC source: 0000950170-24-074741 · ownership.xml · derivative · entry 4

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,651

Underlying: Common Stock · 65,651 shares

Expires 2034-01-17

F5 · derivative.exercise_date: Options were granted on January 17, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan. These options vest as to 50% of the underlying shares on June 27, 2024 and 50% of the underlying shares on September 27, 2024. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 1,313,020 Stock Options with an exercise price of $0.59.

SEC source: 0000950170-24-067851 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,587

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 31, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $10.86 is the closing price of our Common Stock on May 31, 2024, the payroll date for the pay period ending May 31, 2024.

SEC source: 0000950170-24-062201 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,547

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 17, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $10.86 is the closing price of our Common Stock on May 17, 2024, the payroll date for the pay period ending May 17, 2024.

SEC source: 0000950170-24-054013 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,045

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 3, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

F2 · price: $13.07 is the closing price of our Common Stock on May 3, 2024, the payroll date for the pay period ending May 3, 2024.

SEC source: 0000950170-24-046294 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,797

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending April 19, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $5.31 is the closing price of our Common Stock on April 19, 2024, the payroll date for the pay period ending April 19, 2024.

SEC source: 0000950170-24-042533 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,335,325

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending April 5, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.50 is the closing price of our Common Stock on April 5, 2024, the payroll date for the pay period ending April 5, 2024.

SEC source: 0001493152-24-012068 · ownership.xml · derivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: PTIX Common Stock, Par Value $0.0001 · 250,000 shares

Expires 2034-03-25

SEC source: 0000950170-24-035663 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,302,628

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending March 22, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.55 is the closing price of our Common Stock on March 22, 2024, the payroll date for the pay period ending March 22, 2024.

SEC source: 0000950170-24-029346 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,275,465

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending March 8, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.67 is the closing price of our Common Stock on March 8, 2024, the payroll date for the pay period ending March 8, 2024.

SEC source: 0000950170-24-020660 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,253,329

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending February 23, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.68 is the closing price of our Common Stock on February 23, 2024, the payroll date for the pay period ending February 23, 2024.

SEC source: 0000950170-24-016075 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 625,969

F1 · price: Open market purchases occurred at a weighted average price of $0.6481 (range of $0.6173 to $0.6525).

F2 · ownership.nature: Shares are held in Dr. Armen's IRA accounts.

SEC source: 0000950170-24-013671 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,231,514

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending February 9, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.75 is the closing price of our Common Stock on February 9, 2024, the payroll date for the pay period ending February 9, 2024.

SEC source: 0000950170-24-008196 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,211,736

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending January 26, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.66 is the closing price of our Common Stock on January 26, 2024, the payroll date for the pay period ending January 26, 2024.

SEC source: 0000950170-24-004632 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,439,261

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending January 12, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.64 is the closing price of our Common Stock on January 12, 2024, the payroll date for the pay period ending January 12, 2024.

SEC source: 0000950170-24-000573 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,416,084

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending December 29, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.83 is the closing price of our Common Stock on December 29, 2023, the payroll date for the pay period ending December 29, 2023.

SEC source: 0000950170-23-070975 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,396,538

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending December 15, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.69 is the closing price of our Common Stock on December 15, 2023, the payroll date for the pay period ending December 15, 2023.

SEC source: 0000950170-23-067485 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,373,085

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending December 1, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.78 is the closing price of our Common Stock on December 1, 2023, the payroll date for the pay period ending December 1, 2023.

SEC source: 0000950170-23-064994 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,352,358

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending November 17, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.69 is the closing price of our Common Stock on November 17, 2023, the payroll date for the pay period ending November 17, 2023.

SEC source: 0000950170-23-059038 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,328,847

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending November 3, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.84 is the closing price of our Common Stock on November 3, 2023, the payroll date for the pay period ending November 3, 2023.

SEC source: 0000950170-23-054523 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,309,647

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending October 20, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.89 is the closing price of our Common Stock on October 20, 2023, the payroll date for the pay period ending October 20, 2023.

SEC source: 0000899243-23-019942 · doc4.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,291,505

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending October 6, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $1.06 is the closing price of our Common Stock on October 6, 2023, the payroll date for the pay period ending October 6, 2023.

SEC source: 0000950170-23-049605 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,276,200

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending September 22, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $1.18 is the closing price of our Common Stock on September 22, 2023, the payroll date for the pay period ending September 22, 2023.

SEC source: 0000950170-23-047367 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,262,312

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending September 8, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $1.23 is the closing price of our Common Stock on September 8, 2023, the payroll date for the pay period ending September 8, 2023.

SEC source: 0000950170-23-018413 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,866,400

F1 · kind: On May 5, 2023, Garo Armen sold 100,000 shares of Mink Therapeutics, Inc. common stock to Agenus Inc. at the acquisition price he paid on May 2, 2023. The acquisition price represents a 40% discount to the market price as of today's market close. Garo Armen did not recognize a profit upon the sale of the shares.

SEC source: 0000950170-23-018042 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,978,010

SEC source: 0000899243-23-001964 · doc4.xml · derivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-01-16

F1 · derivative.exercise_date: An option to purchase Common Stock was awarded to Dr. Armen for his service as MiNK Therapeutic Inc.'s Chairman of the Board. The option was granted on January 16, 2023 and was awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. The option will vest on January 16, 2024.

SEC source: 0000899243-23-001330 · doc4.xml · derivative · entry 4

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,400,000

Underlying: Common Stock · 2,400,000 shares

Expires 2033-01-05

F5 · derivative.exercise_date: Option was granted on January 5, 2023 and awarded in accordance with the 2019 Plan. Option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter.

SEC source: 0000899243-23-001330 · doc4.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,249,167

F1 · security: Reflects the executive's 2022 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 50% of the award released on March 24, 2023 and 50% of the award released on June 24, 2023.

F2 · price: $2.45 was the fair market value of Agenus Common Stock on January 5, 2023, the stock issuance date.

SEC source: 0000899243-22-004867 · doc4.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,007,784

F1 · security: Reflects the executive's 2021 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a 6-month lockup restriction with 25% of the award released on the 3-month anniversary of the issuance date and 75% of the award released on the 6-month anniversary.

F2 · price: $2.51 was the fair market value of our Common Stock on February 2, 2022, the stock issuance date.

SEC source: 0000899243-22-000599 · doc4.xml · derivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,900,000

Underlying: Common Stock · 1,900,000 shares

Expires 2032-01-02

F1 · derivative.exercise_date: One-third of the stock options vest on the one-year anniversary of the date of grant, with the remainder vesting in equal quarterly installments thereafter; provided that the Reporting Person maintains a service relationship with the Issuer through each such vesting date.